Inscrição na biblioteca: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publicou 6 edições por ano

ISSN Imprimir: 0743-4863

ISSN On-line: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Ancient and Advanced Approaches for the Treatment of an Inflammatory Autoimmune Disease−Psoriasis

Volume 31, Edição 4, 2014, pp. 331-364
DOI: 10.1615/CritRevTherDrugCarrierSyst.2014010122
Get accessGet access

RESUMO

Psoriasis is a chronic, proliferative, and inflammatory skin disease with reactive abnormal epidermal differentiation and hyperproliferation that affects 2−3% of the global population. Various types of psoriasis have been identified by clinical outcomes such as skin biopsies and blood analysis: plaque psoriasis, flexural psoriasis, guttate psoriasis, pustular psoriasis, psoriatic arthritis, scalp psoriasis, nail psoriasis, and erythrodermic psoriasis. The major factors which may be considered as causes of psoriasis are bacterial infections or other infection triggers, genetics, environment, immune disorders, weather, stress triggers, and skin injury. Various ancient approaches such as acupuncture, water treatment, and dietary treatment are available to help control psoriasis, but they are only able to relieve symptoms. Currently, numerous advanced strategies are based on the type of psoriasis, its location, extent, and severity. Nanotechnological approaches, biological approaches, photodynamic therapy, and PUVA (psoralens + UVA) therapy have been successfully used induce a reduction of psoriasis for months to years. These well-tolerated therapies, which have long-lasting remission and improve quality of life, are effective in 80−85% of patients. In this review, we describe different ancient therapies and advanced approaches to treating moderate-to-severe psoriasis that are on the market or currently in clinical trials.

CITADO POR
  1. Kaur Prabhjot, Garg Tarun, Vaidya Bhuvaneshwar, Prakash Atish, Rath Goutam, Goyal Amit K., Brain delivery of intranasalin situgel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment, Journal of Drug Targeting, 23, 3, 2015. Crossref

  2. Kaur Prabhjot, Garg Tarun, Rath Goutam, Murthy R. S. Rayasa, Goyal Amit K., Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design, Drug Delivery, 2014. Crossref

  3. Rohilla Raman, Garg Tarun, Bariwal Jitender, Goyal Amit K., Rath Goutam, Development, optimization and characterization of glycyrrhetinic acid–chitosan nanoparticles of atorvastatin for liver targeting, Drug Delivery, 23, 7, 2016. Crossref

  4. Lotti T., Erfolgreiche Kombinationsbehandlung der Psoriasis mit Phototherapie und niedrig dosierten Zytokinen, Der Hautarzt, 66, 11, 2015. Crossref

  5. Kaur Gurmeet, Garg Tarun, Rath Goutam, Goyal Amit K., Archaeosomes: an excellent carrier for drug and cell delivery, Drug Delivery, 23, 7, 2016. Crossref

  6. Chaudhary Sushant, Garg Tarun, Rath Goutam, Murthy Rs Rayasa, Goyal Amit K., Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis, Artificial Cells, Nanomedicine, and Biotechnology, 2015. Crossref

  7. Garg Tarun, Bhandari Saurav, Rath Goutam, Goyal Amit K., Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor, Journal of Drug Targeting, 23, 10, 2015. Crossref

  8. Garg Tarun, Rath Goutam, Goyal Amit K., Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis, Artificial Cells, Nanomedicine, and Biotechnology, 2015. Crossref

  9. Rath Goutam, Hussain Taqadus, Chauhan Gaurav, Garg Tarun, Kumar Goyal Amit, Fabrication and characterization of cefazolin-loaded nanofibrous mats for the recovery of post-surgical wound, Artificial Cells, Nanomedicine, and Biotechnology, 44, 8, 2016. Crossref

  10. Sharma Aman Kumar, Garg Tarun, Goyal Amit K., Rath Goutam, Role of microemuslsions in advanced drug delivery, Artificial Cells, Nanomedicine, and Biotechnology, 2015. Crossref

  11. Malik Raffi, Garg Tarun, Goyal Amit K., Rath Goutam, Diacerein-Loaded novel gastroretentive nanofiber system using PLLA: Development andin vitrocharacterization, Artificial Cells, Nanomedicine, and Biotechnology, 2015. Crossref

  12. Kaur Prabhjot, Garg Tarun, Rath Goutam, Goyal Amit K., In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane, Artificial Cells, Nanomedicine, and Biotechnology, 2015. Crossref

  13. Singh Jagdeep, Garg Tarun, Rath Goutam, Goyal Amit K., Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review, Drug Delivery, 23, 5, 2016. Crossref

  14. Dhiman Neerupma, Awasthi Rajendra, Sharma Bhupesh, Kharkwal Harsha, Kulkarni Giriraj T., Lipid Nanoparticles as Carriers for Bioactive Delivery, Frontiers in Chemistry, 9, 2021. Crossref

  15. Yadav Nishu, Aggarwal Rohan, Targhotra Monika, Sahoo Prabhat K., Chauhan Meenakshi K., Natural and Nanotechnology Based Treatment: An Alternative Approach to Psoriasis, Current Nanomedicine, 11, 1, 2021. Crossref

  16. Pabreja Swati, Garg Tarun, Rath Goutam, Goyal Amit K., Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes, Artificial Cells, Nanomedicine, and Biotechnology, 44, 2, 2016. Crossref

  17. Patrushev A. V., Sukharev A. V., Ivanov A. M., Samtsov A. V., Role of nidi of infection in various skin diseases, Vestnik dermatologii i venerologii, 91, 5, 2015. Crossref

  18. Sharma Rahul, Garg Tarun, Goyal Amit K., Rath Goutam, Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis, Artificial Cells, Nanomedicine, and Biotechnology, 44, 2, 2016. Crossref

  19. Singh Baljeet, Garg Tarun, Goyal Amit K., Rath Goutam, Development, optimization, and characterization of polymeric electrospun nanofiber: a new attempt in sublingual delivery of nicorandil for the management of angina pectoris, Artificial Cells, Nanomedicine, and Biotechnology, 44, 6, 2016. Crossref

  20. Garg Tarun, Rath Goutam, Goyal Amit K., Nanotechnological approaches for the effective management of psoriasis, Artificial Cells, Nanomedicine, and Biotechnology, 44, 6, 2016. Crossref

  21. Xiang Yu, Wu Xing, Lu Chuanjian, Wang Kaiyi, An overview of acupuncture for psoriasis vulgaris, 2009–2014, Journal of Dermatological Treatment, 28, 3, 2017. Crossref

  22. Shaif Mohammad, Kushwaha Poonam, Usmani Shazia, Pandey Supriya, Exploring the potential of nanocarriers in antipsoriatic therapeutics, Journal of Dermatological Treatment, 2022. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain